The Impact of Interfering Substances on Continuous Glucose Monitors Part 3: A Review of Non-labeled Substances Influencing Continuous Glucose Monitor Readings. [PDF]
J Diabetes Sci TechnolSetford SJ.
europepmc +1 more source
In vivo pharmacokinetics of levodopa and 3-O-methyldopa in muscle [PDF]
, 1992 Dirk Deleu +3 more
openalex +1 more source
Antihypertensive therapy for pregnancy hypertension and implications for fetal and neonatal heart rate monitoring: A systematic review of randomized trials and observational studies. [PDF]
Acta Obstet Gynecol ScandGaneshamoorthy A +9 more
europepmc +1 more source
Methyldopa-induced connective tissue disorder.
, 1986 M. J. Power, J. G. McConnell, I Taylor
openalex
Letter: Rebound hypertension after acute methyldopa withdrawal. [PDF]
, 1976 J SCOTT, DG McDevitt
openalex +1 more source
The Association of Fetal and Maternal Thrombospondin-1 (TSP-1) and Vascular Endothelial Growth Factor (VEGF) Serum Levels with Selected Fetal and Maternal Characteristics. [PDF]
Risk Manag Healthc PolicyObeidat RA +6 more
europepmc +1 more source
ADRENERGIC TRANSMITTER CHANGES AND RESPONSE TO SYMPATHETIC NERVE STIMULATION AFTER DIFFERING PRETREATMENT WITH α‐METHYLDOPA [PDF]
, 1967 W. Haefely, A. HORLIMANN, H. Thoenen
openalex +1 more source
Postnatal and long-term outcomes after in utero exposure to RAAS inhibitors: cohort study based on German claims data. [PDF]
Pediatr NephrolSchink T +6 more
europepmc +1 more source
Protein - Quinone Interaction: In Vitro Induction of Indirect Antiglobulin Reactions With Methyldopa [PDF]
, 1974 Arlan J. Gottlieb, Harold A. Wurzel
openalex +1 more source